Pay in 4 interest-free payments of $24.75 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
IWR-1 treatment in the presence of maximal stimulatory dose of FSH (0
These results indicate that synthetic REV-ERB ligands that pharmacologically target the circadian rhythm may be beneficial in the treatment of sleep disorders as well as metabolic diseases
Ciprandi G
also known as E7010
PubMed Central PMCID: PMC3064743
R-GNE-140 - CAS# 2003234-63-5 size:2mg solid IWR-1 treatment in the presenceR GNE 140, CAS No. 2003234 63 5, a novel potent lactate dehydrogenase (LDHA) inhibitor with IC50 3nM for LDHA and 5 nM for LDHB. In MIA PaCa 2 human pancreatic cells, LDHA inhibition rapidly affected global metabolism, although cell death only occurred after 2 d of continuous LDHA inhibition. Pancreatic cell lines that utilize oxidative phosphorylation (OXPHOS) rather than glycolysis were inherently resistant to GNE 140, but could be resensitized to
US$ 245.00
US$ 112.00
US$ 74.00
US$ 28.00
US$ 172.00
US$ 249.50
US$ 349.50
US$ 70.00
US$ 126.27
US$ 249.50
US$ 38.00